JTL — Jayex Technology Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- AU$0.28m
- AU$3.81m
- AU$3.70m
Annual cashflow statement for Jayex Technology, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | — | 0.545 | 0.461 | 0.094 | 0.242 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 0.175 | -0.183 | -1.26 | -0.856 | -1.84 |
Capital Expenditures | -1.47 | -0.271 | -0.135 | — | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.007 | 0 | -0.635 | 0.429 | 0 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -1.47 | -0.271 | -0.77 | 0.429 | 0 |
Financing Cash Flow Items | — | -0.026 | -0.041 | -0.021 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.16 | 1.35 | 1.82 | -0.282 | 1.66 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.137 | 0.901 | -0.199 | -0.743 | -0.185 |